Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers

NCT00502216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Smoking
Nicotine Dependence

Interventions

DRUG: Naltrexone
DRUG: Varenicline

Sponsor

Yale University

Collaborators

[object Object]
[object Object]